IRE: Financial Software - The Leaner Machine Faces Its Moment of Truth
IRE: Financial Software - The Leaner Machine Faces Its Moment of Truth
In a Nutshell
Executive Summary
In a Nutshell
Iress sells software to financial advisers, brokers, and wealth managers across Australia, the UK, and Asia. At A$7.56 versus our fair value of A$6.43, the stock is overvalued by 15%. The gap is not a fundamental disagreement — at normalised interest rates, our model converges to A$7.40 — but with the RBA hiking again in February 2026, rate relief is not imminent, and the new CEO's strategy remains unproven.
Investor Profiles
| Profile | Rating | Rationale |
|---|---|---|
| Income | ★★★☆☆ | The reinstated dividend of 24 cents per share yields roughly 3.2% at the current price, partially franked at around 35%. The payout is covered 1.8 times by earnings and grows modestly as profits rise. Income investors get a reliable cheque, but the yield is not compelling enough on its own to justify buying above fair value. |
| Value | ★★★☆☆ | At 10.6 times forward EBITDA, Iress trades at a 20–25% discount to global software peers, which typically fetch 12–14 times. The discount reflects legitimate concerns — new CEO, limited track record — but may be excessive given the 85% recurring revenue base. A re-rating toward 12 times would imply a share price near A$8.60, but the catalyst requires patience until at least August 2026. |
| Growth | ★★☆☆☆ | Revenue is growing at 5–6% annually, and earnings per share growth is modest rather than accelerating. The DBFO regulatory tailwind in Australia expands the addressable market, but Iress is gaining market share slowly, not rapidly. Growth investors seeking double-digit compounding will likely find better opportunities elsewhere. |
| Quality | ★★★☆☆ | The business earns a return on invested capital of around 15%, supported by a genuine competitive moat in Australian financial advice software. Management credibility is solid on delivered metrics, but the CEO has been in the role only three months. The two-year clean financial history post-transformation limits the confidence any quality investor can reasonably place in the numbers. |
| Thematic | ★★☆☆☆ | Iress benefits from Australia's Delivering Better Financial Outcomes legislation, which mandates more advice and compliance software spending. The AI integration story is real but early-stage. The thematic appeal is genuine but not differentiated — platform peers like HUB24 and Netwealth offer purer exposure to the same regulatory tailwind with more direct earnings leverage. |
The best fit is the patient value investor. Iress trades at a meaningful discount to software peers, earns a solid return on capital, and is mid-way through a margin expansion program with a credible delivery record. The payoff requires waiting for August 2026's half-year results to confirm the structural margin thesis — but for investors who can tolerate that timeline, the risk-reward improves materially if interest rates normalise.
Executive Summary
Iress sells subscription software to financial advisers, stockbrokers, and wealth managers. It earns 85% of its revenue from recurring contracts, making cash flows predictable and clients sticky. The business operates across three segments: global trading and market data (half of revenue), Australian and Asian wealth management software, and UK wealth management.
The past two years have been defined by deliberate shrinkage. Iress divested five non-core businesses, hired a new chief executive in November 2025, and launched a $30 million annual cost reduction program — 60% of which is already delivered. The result is a leaner company: EBITDA margins rose from 24.4% in FY24 to 26.3% in FY25, and free cash flow improved meaningfully.
The investment case rests on two things: whether the remaining efficiency savings arrive on schedule, and whether the regulatory tailwind from Australia's advice legislation drives accelerating growth in the highest-margin segment. Both are plausible — but neither is certain under a new CEO with no disclosed equity stake and three months in the chair.
At A$7.56 versus our fair value of A$6.43, the stock is overvalued by 15%.
Results & Outlook
What happened?
FY25 was a solid year on the numbers that mattered. Revenue on a continuing basis grew 6.5% to $504 million, driven by the global trading segment and a recovery in UK wealth. More importantly, the cost reduction program delivered ahead of schedule — EBITDA margins expanded by nearly two percentage points, and free cash flow rose from a low base to $63 million. The dividend was reinstated at 24 cents, signalling management confidence in the recurring cash generation.
| Metric | FY24A | FY25A | FY26E | FY27E |
|---|---|---|---|---|
| Revenue ($m) | 473.4 | 504.3 | 529.6 | 556.9 |
| EBITDA ($m) | 115.4 | 132.6 | 148.3 | 153.2 |
| EBITDA Margin | 24.4% | 26.3% | 28.0% | 27.5% |
| Free Cash Flow ($m) | — | 63.4 | 75.1 | 78.1 |
| DPS (cents) | — | 24.0 | 22.5 | 23.0 |
| ROIC | — | 15.0% | 14.5% | 14.0% |
What's next?
Management has guided for FY26 revenue of $520–528 million and a Cash EBITDA margin exit rate above 25% by year-end. Our forecast sits at the top of that range. The remaining $12 million of annualised cost savings are expected to land in the second half of FY26 — making the August 2026 half-year result the single most important data point for this thesis.
The Australian wealth segment carries the most upside. Legislation requiring more financial advisers to use compliant advice software is working its way through implementation, and Iress holds roughly 60–65% market share in this category. A partnership with Challenger confirmed during FY25 illustrates how the regulatory cycle is already generating new commercial relationships.
The UK segment is the watch item. Growth in constant currency is running at only 2%, and competitive pressure from newer cloud-native platforms is real, even if management frames it primarily as market-wide softness.
Valuation & Risks
| Metric | Value |
|---|---|
| Fair Value | A$6.43 |
| Current Price | A$7.56 |
| Overvalued by | 15% |
| Bull Case | A$8.22 (20% probability) |
| Bear Case | A$4.73 (20% probability) |
| EV/EBITDA (current) | 10.6× NTM |
| EV/EBITDA (peer median) | 12–14× |
Our fair value of A$6.43 blends a discounted cash flow model (53% weight) with a trading multiples cross-check (42% weight). The 15% gap to the current price is almost entirely explained by the discount rate: we use a 9.8% cost of capital anchored to Australian 10-year bond yields sitting near a five-year high. At a normalised rate of 8%, fair value rises to approximately A$7.40 — within two cents of where the market is trading today. This is not a business in distress; it is a business being mechanically discounted by elevated rates.
The biggest risk to this view is not the interest rate — it is the new CEO. Andrew Russell has been in the role for three months, has not disclosed an equity stake, and has not yet committed to a specific capital allocation framework. If he chooses to reinvest the hard-won efficiency savings into a large acquisition or accelerated technology spending, the margin expansion thesis unravels. Development capital expenditure already doubled in FY25 to $27 million. A further step-up above 7% of revenue would be the early warning signal worth watching.